352 related articles for article (PubMed ID: 18294845)
1. Vinyl ester-based cyclic peptide proteasome inhibitors.
Baldisserotto A; Marastoni M; Fiorini S; Pretto L; Ferretti V; Gavioli R; Tomatis R
Bioorg Med Chem Lett; 2008 Mar; 18(6):1849-54. PubMed ID: 18294845
[TBL] [Abstract][Full Text] [Related]
2. New cyclic peptide proteasome inhibitors.
Baldisserotto A; Marastoni M; Gavioli R; Tomatis R
Bioorg Med Chem Lett; 2009 Apr; 19(7):1966-9. PubMed ID: 19250821
[TBL] [Abstract][Full Text] [Related]
3. Peptidyl vinyl ester derivatives: new class of selective inhibitors of proteasome trypsin-like activity.
Marastoni M; Baldisserotto A; Cellini S; Gavioli R; Tomatis R
J Med Chem; 2005 Jul; 48(15):5038-42. PubMed ID: 16033282
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides.
Baldisserotto A; Franceschini C; Scalambra F; Trapella C; Marastoni M; Sforza F; Gavioli R; Tomatis R
J Pept Sci; 2010 Nov; 16(11):659-63. PubMed ID: 20814885
[TBL] [Abstract][Full Text] [Related]
5. Novel CADD-based peptidyl vinyl ester derivatives as potential proteasome inhibitors.
Mou K; Xu B; Ma C; Yang X; Zou X; Lü Y; Xu P
Bioorg Med Chem Lett; 2008 Mar; 18(6):2198-202. PubMed ID: 18280155
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors.
Marastoni M; Baldisserotto A; Trapella C; Gavioli R; Tomatis R
Eur J Med Chem; 2006 Aug; 41(8):978-84. PubMed ID: 16713026
[TBL] [Abstract][Full Text] [Related]
7. Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit.
Baldisserotto A; Marastoni M; Trapella C; Gavioli R; Ferretti V; Pretto L; Tomatis R
Eur J Med Chem; 2007 May; 42(5):586-92. PubMed ID: 17291631
[TBL] [Abstract][Full Text] [Related]
8. Alpha,beta-unsaturated N-acylpyrrole peptidyl derivatives: new proteasome inhibitors.
Baldisserotto A; Ferretti V; Destro F; Franceschini C; Marastoni M; Gavioli R; Tomatis R
J Med Chem; 2010 Sep; 53(17):6511-5. PubMed ID: 20687609
[TBL] [Abstract][Full Text] [Related]
9. TMC-95-based inhibitor design provides evidence for the catalytic versatility of the proteasome.
Groll M; Götz M; Kaiser M; Weyher E; Moroder L
Chem Biol; 2006 Jun; 13(6):607-14. PubMed ID: 16793518
[TBL] [Abstract][Full Text] [Related]
10. C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors.
Baldisserotto A; Marastoni M; Lazzari I; Trapella C; Gavioli R; Tomatis R
Eur J Med Chem; 2008 Jul; 43(7):1403-11. PubMed ID: 17996987
[TBL] [Abstract][Full Text] [Related]
11. Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors.
Rydzewski RM; Burrill L; Mendonca R; Palmer JT; Rice M; Tahilramani R; Bass KE; Leung L; Gjerstad E; Janc JW; Pan L
J Med Chem; 2006 May; 49(10):2953-68. PubMed ID: 16686537
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibition by peptide-semicarbazones.
Leban J; Blisse M; Krauss B; Rath S; Baumgartner R; Seifert MH
Bioorg Med Chem; 2008 Apr; 16(8):4579-88. PubMed ID: 18313310
[TBL] [Abstract][Full Text] [Related]
13. P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors.
Marastoni M; Baldisserotto A; Trapella C; Gavioli R; Tomatis R
Bioorg Med Chem Lett; 2006 Jun; 16(12):3125-30. PubMed ID: 16603348
[TBL] [Abstract][Full Text] [Related]
14. The natural product hybrid of Syringolin A and Glidobactin A synergizes proteasome inhibition potency with subsite selectivity.
Clerc J; Li N; Krahn D; Groll M; Bachmann AS; Florea BI; Overkleeft HS; Kaiser M
Chem Commun (Camb); 2011 Jan; 47(1):385-7. PubMed ID: 20830349
[TBL] [Abstract][Full Text] [Related]
15. Novel beta-lactam derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.
Imbach P; Lang M; García-Echeverría C; Guagnano V; Noorani M; Roesel J; Bitsch F; Rihs G; Furet P
Bioorg Med Chem Lett; 2007 Jan; 17(2):358-62. PubMed ID: 17095212
[TBL] [Abstract][Full Text] [Related]
16. 20S proteasome inhibition: designing noncovalent linear peptide mimics of the natural product TMC-95A.
Groll M; Gallastegui N; Maréchal X; Le Ravalec V; Basse N; Richy N; Genin E; Huber R; Moroder L; Vidal J; Reboud-Ravaux M
ChemMedChem; 2010 Oct; 5(10):1701-5. PubMed ID: 20715286
[No Abstract] [Full Text] [Related]
17. Synthesis and biological characterization of argyrin F.
Bülow L; Nickeleit I; Girbig AK; Brodmann T; Rentsch A; Eggert U; Sasse F; Steinmetz H; Frank R; Carlomagno T; Malek NP; Kalesse M
ChemMedChem; 2010 Jun; 5(6):832-6. PubMed ID: 20358576
[No Abstract] [Full Text] [Related]
18. Design, synthesis and analysis of novel bicyclic and bifunctional protease inhibitors.
Jaulent AM; Leatherbarrow RJ
Protein Eng Des Sel; 2004 Sep; 17(9):681-7. PubMed ID: 15486024
[TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibitors; synthesis and activity of arecoline oxide tripeptide derivatives.
Marastoni M; McDonald J; Baldisserotto A; Canella A; De Risi C; Pollini GP; Tomatis R
Bioorg Med Chem Lett; 2004 Apr; 14(8):1965-8. PubMed ID: 15050638
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome.
Momose I; Umezawa Y; Hirosawa S; Iinuma H; Ikeda D
Bioorg Med Chem Lett; 2005 Apr; 15(7):1867-71. PubMed ID: 15780623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
